Functional evolution of the 2009 pandemic H1N1 influenza virus NS1 and PA in humans

Journal of Virology

Volumn 92, Issue 19, 2018, Pages

  Nogales, Aitor ^a   Martinez Sobrido, Luis ^a   Chiem, Kevin ^a   Topham, David J ^a   DeDiego, Marta L ^a,b  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

Author keywords

Gene expression inhibition; Inflammatory responses; Influenza virus; Innate immunity; Interferon responses; NS1; PA X

Indexed keywords

INS1 PROTEIN, INFLUENZA VIRUS; PA PROTEIN, INFLUENZA VIRUSES; PA-X PROTEIN, INFLUENZA A VIRUS; REPRESSOR PROTEIN; RNA DIRECTED RNA POLYMERASE; VIRAL PROTEIN;

AMINO ACID SUBSTITUTION; ANIMAL; GENE EXPRESSION REGULATION; GENETICS; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOLOGY; INFLUENZA; INFLUENZA A VIRUS (H1N1); INNATE IMMUNITY; MOLECULAR EVOLUTION; MOUSE; MUTATION RATE; ORTHOMYXOVIRUS INFECTION; PANDEMIC; PATHOGENICITY; PIG; SIGNAL TRANSDUCTION; VETERINARY MEDICINE; VIROLOGY; VIRULENCE; VIRUS REPLICATION;

AMINO ACID SUBSTITUTION; ANIMALS; EVOLUTION, MOLECULAR; GENE EXPRESSION REGULATION; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MICE; MUTATION RATE; ORTHOMYXOVIRIDAE INFECTIONS; PANDEMICS; REPRESSOR PROTEINS; RNA REPLICASE; SIGNAL TRANSDUCTION; SWINE; VIRAL NONSTRUCTURAL PROTEINS; VIRAL PROTEINS; VIRULENCE; VIRUS REPLICATION;

EID: 85053399205     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01206-18     Document Type: Article

References (62)

1. Trifonov V, Khiabanian H, Rabadan R. 2009. Geographic dependence, surveillance, and origins of the 2009 influenza A (H1N1) virus. N Engl J Med 361:115–119. https://doi.org/10.1056/NEJMp0904572.
2. Garten RJ, Davis CT, Russell CA, Shu B, Lindstrom S, Balish A, Sessions WM, Xu X, Skepner E, Deyde V, Okomo-Adhiambo M, Gubareva L, Barnes J, Smith CB, Emery SL, Hillman MJ, Rivailler P, Smagala J, de Graaf M, Burke DF, Fouchier RA, Pappas C, Alpuche-Aranda CM, Lopez-Gatell H, Olivera H, Lopez I, Myers CA, Faix D, Blair PJ, Yu C, Keene KM, Dotson PD, Jr, Boxrud D, Sambol AR, Abid SH, St George K, Bannerman T, Moore AL, Stringer DJ, Blevins P, Demmler-Harrison GJ, Ginsberg M, Kriner P, Waterman S, Smole S, Guevara HF, Belongia EA, Clark PA, Beatrice ST, Donis R, et al. 2009. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 325: 197–201. https://doi.org/10.1126/science.1176225.
3. Girard MP, Cherian T, Pervikov Y, Kieny MP. 2005. A review of vaccine research and development: human acute respiratory infections. Vaccine 23:5708–5724. https://doi.org/10.1016/j.vaccine.2005.07.046.
4. Iwasaki A, Pillai PS. 2014. Innate immunity to influenza virus infection. Nat Rev Immunol 14:315–328. https://doi.org/10.1038/nri3665.
5. Klemm C, Boergeling Y, Ludwig S, Ehrhardt C. 17 January 2018. Immu-nomodulatory nonstructural proteins of influenza A viruses. Trends Microbiol https://doi.org/10.1016/j.tim.2017.12.006.
6. Resa-Infante P, Jorba N, Coloma R, Ortin J. 2011. The influenza virus RNA synthesis machine: advances in its structure and function. RNA Biol 8:207–215. https://doi.org/10.4161/rna.8.2.14513.
7. Jagger BW, Wise HM, Kash JC, Walters KA, Wills NM, Xiao YL, Dunfee RL, Schwartzman LM, Ozinsky A, Bell GL, Dalton RM, Lo A, Efstathiou S, Atkins JF, Firth AE, Taubenberger JK, Digard P. 2012. An overlapping protein-coding region in influenza A virus segment 3 modulates the host response. Science 337:199–204. https://doi.org/10.1126/science.1222213.
8. Hayashi T, MacDonald LA, Takimoto T. 2015. Influenza A virus protein PA-X contributes to viral growth and suppression of the host antiviral and immune responses. J Virol 89:6442–6452. https://doi.org/10.1128/JVI.00319-15.
9. Hu J, Mo Y, Wang X, Gu M, Hu Z, Zhong L, Wu Q, Hao X, Hu S, Liu W, Liu H, Liu X, Liu X. 2015. PA-X decreases the pathogenicity of highly pathogenic H5N1 influenza A virus in avian species by inhibiting virus replication and host response. J Virol 89:4126 – 4142. https://doi.org/10.1128/JVI.02132-14.
10. Khaperskyy DA, McCormick C. 2015. Timing is everything: coordinated control of host shutoff by influenza A virus NS1 and PA-X proteins. J Virol 89:6528 – 6531. https://doi.org/10.1128/JVI.00386-15.
11. Khaperskyy DA, Schmaling S, Larkins-Ford J, McCormick C, Gaglia MM. 2016. Selective degradation of host RNA polymerase II transcripts by influenza A virus PA-X host shutoff protein. PLoS Pathog 12:e1005427. https://doi.org/10.1371/journal.ppat.1005427.
12. Oishi K, Yamayoshi S, Kawaoka Y. 2015. Mapping of a region of the PA-X protein of influenza A virus that is important for its shutoff activity. J Virol 89:8661–8665. https://doi.org/10.1128/JVI.01132-15.
13. Hayashi T, Chaimayo C, McGuinness J, Takimoto T. 2016. Critical role of the PA-X C-terminal domain of influenza A virus in its subcellular localization and shutoff activity. J Virol 90:7131–7141. https://doi.org/10.1128/JVI.00954-16.
14. Bavagnoli L, Cucuzza S, Campanini G, Rovida F, Paolucci S, Baldanti F, Maga G. 2015. The novel influenza A virus protein PA-X and its naturally deleted variant show different enzymatic properties in comparison to the viral endonuclease PA. Nucleic Acids Res 43:9405–9417. https://doi.org/10.1093/nar/gkv926.
15. Desmet EA, Bussey KA, Stone R, Takimoto T. 2013. Identification of the N-terminal domain of the influenza virus PA responsible for the suppression of host protein synthesis. J Virol 87:3108–3118. https://doi.org/10.1128/JVI.02826-12.
16. Gao HJ, Sun HL, Hu J, Wang JL, Xiong X, Wang Y, He QM, Lin Y, Kong WL, Seng LG, Pu J, Chang KC, Liu XF, Liu JH, Sun YP. 2015. Twenty amino acids at the C-terminus of PA-X are associated with increased influenza A virus replication and pathogenicity. J Gen Virol 96:2036–2049. https:// doi.org/10.1099/vir.0.000143.
17. Gao HJ, Xu GL, Sun YP, Qi L, Wang JL, Kong WL, Sun HL, Pu J, Chang KC, Liu JH. 2015. PA-X is a virulence factor in avian H9N2 influenza virus. J Gen Virol 96:2587–2594. https://doi.org/10.1099/jgv.0.000232.
18. Hu J, Mo YQ, Gao Z, Wang XQ, Gu M, Liang YY, Cheng X, Hu SL, Liu WB, Liu HM, Chen SJ, Liu XW, Peng DX, Liu XF. 2016. PA-X-associated early alleviation of the acute lung injury contributes to the attenuation of a highly pathogenic H5N1 avian influenza virus in mice. Med Microbiol Immunol 205:381–395. https://doi.org/10.1007/s00430-016-0461-2.
19. Nogales A, Rodriguez L, DeDiego ML, Topham DJ, Martinez-Sobrido L. 2017. Interplay of PA-X and NS1 proteins in replication and pathogenesis of a temperature-sensitive 2009 pandemic H1N1 influenza A virus. J Virol 91:e00720-17. https://doi.org/10.1128/JVI.00720-17.
20. Hale BG, Randall RE, Ortin J, Jackson D. 2008. The multifunctional NS1 protein of influenza A viruses. J Gen Virol 89:2359–2376. https://doi.org/10.1099/vir.0.2008/004606-0.
21. Garcia-Sastre A, Egorov A, Matassov D, Brandt S, Levy DE, Durbin JE, Palese P, Muster T. 1998. Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. Virology 252:324–330. https://doi.org/10.1006/viro.1998.9508.
22. DeDiego ML, Nogales A, Lambert-Emo K, Martinez-Sobrido L, Topham DJ. 2016. NS1 protein mutation I64T affects interferon responses and virulence of circulating H3N2 human influenza A viruses. J Virol 90: 9693–9711. https://doi.org/10.1128/JVI.01039-16.
23. Nogales A, Martinez-Sobrido L, Topham DJ, DeDiego ML. 2017. NS1 protein amino acid changes D189N and V194I affect interferon responses, thermosensitivity, and virulence of circulating H3N2 human influenza A viruses. J Virol 91:e01930-16. https://doi.org/10.1128/JVI.01930-16.
24. Nogales A, Huang K, Chauche C, DeDiego ML, Murcia PR, Parrish CR, Martinez-Sobrido L. 2017. Canine influenza viruses with modified NS1 proteins for the development of live-attenuated vaccines. Virology 500: 1–10. https://doi.org/10.1016/j.virol.2016.10.008.
25. Quinlivan M, Zamarin D, Garcia-Sastre A, Cullinane A, Chambers T, Palese P. 2005. Attenuation of equine influenza viruses through truncations of the NS1 protein. J Virol 79:8431– 8439. https://doi.org/10.1128/JVI.79.13.8431-8439.2005.
26. Pica N, Langlois RA, Krammer F, Margine I, Palese P. 2012. NS1-truncated live attenuated virus vaccine provides robust protection to aged mice from viral challenge. J Virol 86:10293–10301. https://doi.org/10.1128/JVI.01131-12.
27. Donelan NR, Basler CF, Garcia-Sastre A. 2003. A recombinant influenza A virus expressing an RNA-binding-defective NS1 protein induces high levels of beta interferon and is attenuated in mice. J Virol 77: 13257–13266. https://doi.org/10.1128/JVI.77.24.13257-13266.2003.
28. Guo Z, Chen LM, Zeng H, Gomez JA, Plowden J, Fujita T, Katz JM, Donis RO, Sambhara S. 2007. NS1 protein of influenza A virus inhibits the function of intracytoplasmic pathogen sensor, RIG-I. Am J Respir Cell Mol Biol 36:263–269. https://doi.org/10.1165/rcmb.2006-0283RC.
29. Mibayashi M, Martinez-Sobrido L, Loo YM, Cardenas WB, Gale M, Jr, Garcia-Sastre A. 2007. Inhibition of retinoic acid-inducible gene I-mediated induction of beta interferon by the NS1 protein of influenza A virus. J Virol 81:514–524. https://doi.org/10.1128/JVI.01265-06.
30. Opitz B, Rejaibi A, Dauber B, Eckhard J, Vinzing M, Schmeck B, Hippen-stiel S, Suttorp N, Wolff T. 2007. IFNbeta induction by influenza A virus is mediated by RIG-I which is regulated by the viral NS1 protein. Cell Microbiol 9:930–938. https://doi.org/10.1111/j.1462-5822.2006.00841.x.
31. Gack MU, Albrecht RA, Urano T, Inn KS, Huang IC, Carnero E, Farzan M, Inoue S, Jung JU, Garcia-Sastre A. 2009. Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I. Cell Host Microbe 5:439–449. https://doi.org/10.1016/j.chom.2009.04.006.
32. Das K, Ma LC, Xiao R, Radvansky B, Aramini J, Zhao L, Marklund J, Kuo RL, Twu KY, Arnold E, Krug RM, Montelione GT. 2008. Structural basis for suppression of a host antiviral response by influenza A virus. Proc Natl Acad Sci U S A 105:13093–13098. https://doi.org/10.1073/pnas .0805213105.
33. Kochs G, Garcia-Sastre A, Martinez-Sobrido L. 2007. Multiple anti-interferon actions of the influenza A virus NS1 protein. J Virol 81: 7011–7021. https://doi.org/10.1128/JVI.02581-06.
34. Nemeroff ME, Barabino SM, Li Y, Keller W, Krug RM. 1998. Influenza virus NS1 protein interacts with the cellular 30 kDa subunit of CPSF and inhibits 3=end formation of cellular pre-mRNAs. Mol Cell 1:991–1000. https://doi.org/10.1016/S1097-2765(00)80099-4.
35. Noah DL, Twu KY, Krug RM. 2003. Cellular antiviral responses against influenza A virus are countered at the posttranscriptional level by the viral NS1A protein via its binding to a cellular protein required for the 3= end processing of cellular pre-mRNAs. Virology 307:386–395. https://doi.org/10.1016/S0042-6822(02)00127-7.
36. Chen Z, Li Y, Krug RM. 1999. Influenza A virus NS1 protein targets poly(A)-binding protein II of the cellular 3=-end processing machinery. EMBO J 18:2273–2283. https://doi.org/10.1093/emboj/18.8.2273.
37. Hale BG, Steel J, Medina RA, Manicassamy B, Ye J, Hickman D, Hai R, Schmolke M, Lowen AC, Perez DR, Garcia-Sastre A. 2010. Inefficient control of host gene expression by the 2009 pandemic H1N1 influenza A virus NS1 protein. J Virol 84:6909–6922. https://doi.org/10.1128/JVI.00081-10.
38. Clark AM, Nogales A, Martinez-Sobrido L, Topham DJ, DeDiego ML. 2017. Functional evolution of influenza virus NS1 protein in currently circulating human 2009 pandemic H1N1 viruses. J Virol 91:e00721-17. https://doi.org/10.1128/JVI.00721-17.
39. Vasin AV, Temkina OA, Egorov VV, Klotchenko SA, Plotnikova MA, Kiselev OI. 2014. Molecular mechanisms enhancing the proteome of influenza A viruses: an overview of recently discovered proteins. Virus Res 185: 53– 63. https://doi.org/10.1016/j.virusres.2014.03.015.
40. Nogales A, DeDiego ML, Topham DJ, Martinez-Sobrido L. 2016. Rearrangement of influenza virus spliced segments for the development of live-attenuated vaccines. J Virol 90:6291–6302. https://doi.org/10.1128/JVI.00410-16.
41. Guo H, Santiago F, Lambert K, Takimoto T, Topham DJ. 2011. T cell-mediated protection against lethal 2009 pandemic H1N1 influenza virus infection in a mouse model. J Virol 85:448–455. https://doi.org/10.1128/JVI.01812-10.
42. Spann KM, Tran KC, Chi B, Rabin RL, Collins PL. 2004. Suppression of the induction of alpha, beta, and lambda interferons by the NS1 and NS2 proteins of human respiratory syncytial virus in human epithelial cells and macrophages. J Virol 78:4363–4369. https://doi.org/10.1128/JVI.78.8.4363-4369.2004.
43. Clark AM, DeDiego ML, Anderson CS, Wang J, Yang H, Nogales A, Martinez-Sobrido L, Zand MS, Sangster MY, Topham DJ. 2017. Antigenicity of the 2015-2016 seasonal H1N1 human influenza virus HA and NA proteins. PLoS One 12:e0188267. https://doi.org/10.1371/journal.pone.0188267.
44. Akira S. 2009. Pathogen recognition by innate immunity and its signaling. Proc Jpn Acad Ser B Phys Biol Sci 85:143–156. https://doi.org/10.2183/pjab.85.143.
45. Cheung CY, Poon LL, Lau AS, Luk W, Lau YL, Shortridge KF, Gordon S, Guan Y, Peiris JS. 2002. Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease? Lancet 360:1831–1837. https://doi.org/10.1016/S0140-6736(02)11772-7.
46. de Jong MD, Simmons CP, Thanh TT, Hien VM, Smith GJD, Chau TNB, Hoang DM, Chau NVV, Khanh TH, Dong VC, Qui PT, Cam BV, Ha DQ, Guan Y, Peiris JSM, Chinh NT, Hien TT, Farrar J. 2006. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytoki-nemia. Nat Med 12:1203–1207. https://doi.org/10.1038/nm1477.
47. Tavares LP, Teixeira MM, Garcia CC. 2017. The inflammatory response triggered by influenza virus: a two edged sword. Inflamm Res 66: 283–302. https://doi.org/10.1007/s00011-016-0996-0.
48. Twu KY, Noah DL, Rao P, Kuo RL, Krug RM. 2006. The CPSF30 binding site on the NS1A protein of influenza A virus is a potential antiviral target. J Virol 80:3957–3965. https://doi.org/10.1128/JVI.80.8.3957-3965.2006.
49. Schmolke M, Garcia-Sastre A. 2010. Evasion of innate and adaptive immune responses by influenza A virus. Cell Microbiol 12:873–880. https://doi.org/10.1111/j.1462-5822.2010.01475.x.
50. Ayllon J, Domingues P, Rajsbaum R, Miorin L, Schmolke M, Hale BG, Garcia-Sastre A. 2014. A single amino acid substitution in the novel H7N9 influenza A virus NS1 protein increases CPSF30 binding and virulence. J Virol 88:12146–12151. https://doi.org/10.1128/JVI.01567-14.
51. Gao H, Sun Y, Hu J, Qi L, Wang J, Xiong X, Wang Y, He Q, Lin Y, Kong W, Seng LG, Sun H, Pu J, Chang KC, Liu X, Liu J. 2015. The contribution of PA-X to the virulence of pandemic 2009 H1N1 and highly pathogenic H5N1 avian influenza viruses. Sci Rep 5:8262. https://doi.org/10.1038/srep08262.
52. Feng KH, Sun M, Iketani S, Holmes EC, Parrish CR. 2016. Comparing the functions of equine and canine influenza H3N8 virus PA-X proteins: suppression of reporter gene expression and modulation of global host gene expression. Virology 496:138–146. https://doi.org/10.1016/j.virol.2016.06.001.
53. Sun Y, Xu Q, Shen Y, Liu L, Wei K, Sun H, Pu J, Chang KC, Liu J. 2014. Naturally occurring mutations in the PA gene are key contributors to increased virulence of pandemic H1N1/09 influenza virus in mice. J Virol 88:4600–4604. https://doi.org/10.1128/JVI.03158-13.
54. Itoh Y, Shinya K, Kiso M, Watanabe T, Sakoda Y, Hatta M, Muramoto Y, Tamura D, Sakai-Tagawa Y, Noda T, Sakabe S, Imai M, Hatta Y, Watanabe S, Li CJ, Yamada S, Fujii K, Murakami S, Imai H, Kakugawa S, Ito M, Takano R, Iwatsuki-Horimoto K, Shimojima M, Horimoto T, Goto H, Takahashi K, Makino A, Ishigaki H, Nakayama M, Okamatsu M, Takahashi K, Warshauer D, Shult PA, Saito R, Suzuki H, Furuta Y, Yamashita M, Mitamura K, Nakano K, Nakamura M, Brockman-Schneider R, Mitamura H, Yamazaki M, Sugaya N, Suresh M, Ozawa M, Neumann G, Gern J, Kida H, et al. 2009. In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 460:1021–1025. https://doi.org/10.1038/nature08260.
55. Ma WJ, Belisle SE, Mosier D, Li X, Stigger-Rosser E, Liu QF, Qiao CL, Elder J, Webby R, Katze MG, Richt JA. 2011. 2009 pandemic H1N1 influenza virus causes disease and upregulation of genes related to inflammatory and immune responses, cell death, and lipid metabolism in pigs. J Virol 85:11626–11637. https://doi.org/10.1128/JVI.05705-11.
56. Baker SF, Guo H, Albrecht RA, García-Sastre A, Topham DJ, Martínez-Sobrido L. 2013. Protection against lethal influenza with a viral mimic. J Virol 87:8591–8605. https://doi.org/10.1128/JVI.01081-13.
57. Martinez-Sobrido L, Garcia-Sastre A. 2010. Generation of recombinant influenza virus from plasmid DNA. J Vis Exp 2010:2057. https://doi.org/10.3791/2057.
58. Nogales A, Baker SF, Martinez-Sobrido L. 2015. Replication-competent influenza A viruses expressing a red fluorescent protein. Virology 476: 206–216. https://doi.org/10.1016/j.virol.2014.12.006.
59. Nogales A, Rodriguez-Sanchez I, Monte K, Lenschow DJ, Perez DR, Martinez-Sobrido L. 2015. Replication-competent fluorescent-expressing influenza B virus. Virus Res 213:69–81. https://doi.org/10.1016/j.virusres.2015.11.014.
60. National Research Council. 2011. Guide for the care and use of laboratory animals, 8th ed. National Academies Press, Washington, DC.
61. Reed LJ, Muench H. 1938. A simple method of estimating fifty per cent endpoints. Am J Hyg (Lond) 27:493–497.
62. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(Delta Delta C(T)) method. Methods 25:402–408. https://doi.org/10.1006/meth.2001.1262.